Regulatory Strategy Consulting Competencies

 

Regulatory Strategy Consulting Competencies - Overview

Freyr is supporting global Top 5 and Fortune Pharma/Biotechnology/Consumer and Medical devices companies with end-to-end strategic Regulatory services for their strategic Regulatory needs across new emerging markets like Africa including South Africa, Sub Sahara and North Africa regions. With a right Regulatory approach as a key function of business consulting, Freyr offers cost-effective product, market and Regulatory pathway strategies to Large & Small-Medium Life Sciences companies, which includes:

  • Drug Registration Pathway
  • Market Strategy Report
  • Marketing Authorization Renewal

Regulatory Strategy Consulting Competencies - Expertise

Gap Analysis
  • Findings, recommendations, approach for transformation
  • Systems repositories, folders, and naming conventions
  • Identify triggers, processes, and workflows across functions
  • Resources, skill sets, location, cross-functional interaction, methodologies, trainings
Transformation
  • Region-wise Phased Implementation
  • Phase-wise Detailed Transition plan
  • Planned resource requirements with a resource model
  • System and infrastructure model with to-be plans and detailed transition approach
Regulatory Strategy
  • Dedicated Regulatory strategy for each product
  • Market analysis with a predictive forecast
  • Experts in communication with Health Authorities worldwide
Current State Assessment
  • Transparent information collection approach
  • Process, technology and information and productivity approach
  • Managements view of risks vs findings with risk management and escalation training and a detailed report on focus areas
ROI Analysis
  • Investment Vs. Annual Savings – volume adjustments for optimum ROI
  • Aggregated and market specific ROIs – Internal vs external resources
  • Transition models – optimum and parallel transitions for higher ROI
Centralization
  • Multiple roll out scenarios
  • Data migration plans
  • Role-based training programs
  • Reducing redundancy and optimizing processes to increase efficiency
Regulatory Strategy Consulting Competencies

Celebrating Customers Success

 

Medicinal Products

Regulatory Affairs

India

Thank you for the timely support over the weekend, which allowed us to resubmit quickly after being notified. This continuously demonstrates Freyr's commitment towards our company’s milestones.

Director - Global Regulatory Affairs – Operations

India-based, Global Top Generic Pharma Company

 

Medicinal Products

Publishing

UK

I am sure you have heard by now that we have received our first-ever approval from the FDA for our Brands division. This is a major milestone for us as well as for my team here in Reg Ops. I would be remiss if I didn’t point out that we would not have been able to do this without the help of your dedicated team. From the original filing, then the following year of responses, all helped get us to final approval.

Thank you Freyr team for a job well done!

Sr. Director, Head of Regulatory Operations

Ireland-based, Global Specialty Pharmaceutical Company

 

Medicinal Products

Regulatory Affairs

USA

Please relate to the team the excellent job they have done on the IND reactivation. Specifically, the high-quality module 3, written by Freyr. It was very comprehensive, very few revisions were required, and we had no questions from Health Canada or FDA. No CMC questions: that was a first for me. So very responsive to my many requests, which I am sure can be frustrating but always helpful while producing excellent work.

Thank you for always being available and responding quickly and comprehensively to all my requests.

What a great team you have, Freyr.

Lynne McGrath

Regulatory Consultant

 

Medicinal Products

Regulatory Affairs

USA

Congratulations!!! ​

Thanks for your great support for a successful ANDA filing, especially to the publishing team. Heartfully appreciate their last hours of hard work.

Assistant Manager​

US-based, Leading, Complex Generic Pharmaceutical Products Company​

 

Medicinal Products

Regulatory Affairs

USA

Thank you all for the great support!​

CEO

US-based, Leading Innovative Pharmaceuticals Company​

 

Medicinal Products

Regulatory Affairs

USA

The ANDA receipt has been received! Thank you very much for your hard work, patience, and support for our work over the last couple of months. We are delighted that we were able to meet the timeline and hit an important corporate goal of our young company. ​

Thank you again, and we look forward to working with your team on the next project!

Senior Director of Business and Product Development​

US-based, Leading Innovator Pharmaceuticals Company​